Ampio pharmaceuticals announces nyse american removal of trading suspension

Englewood, colo. , nov. 17, 2022 /prnewswire/ -- ampio pharmaceuticals, inc. (nyse american/otc pink: ampe) (the "company") received notification from nyse american llc ("nyse american" or the "exchange") stating that the staff of nyse regulation has withdrawn its delisting determination and will be lifting the trading suspension of the company's common stock on the nyse american.

AMPE Ratings Summary

AMPE Quant Ranking